- Korean Medicine Innovative Technologies Development Project: Integrative Advances and Comprehensive Overview of the National R&D Initiative
-
Yoon Jae Lee, Seungwon Shin, Junhyeok Yi, Minjung Park
-
Perspect Integr Med. 2024;3(2):69-73. Published online June 21, 2024
-
DOI: https://doi.org/10.56986/pim.2024.06.002
-
-
1,661
View
-
51
Download
-
3
Citations
-
 Graphical Abstract
 PDF
 -
Citations
Citations to this article as recorded by  - Integrative personalized medicine care for adjustment disorder of a post-COVID-19 patient: A CARE-compliant case report
Won-Kyoung Moon, Ja-Yeon Jeong, Sang-Woo Park, Su-Yeon Yun, Euiju Lee, Seungwon Shin
Medicine.2024; 103(31): e39121. CrossRef - Robust Evidence in Integrative Medicine: Innovations, Challenges, and Future Directions
Ye-Seul Lee, Myeong Soo Lee, David Moher, In-Hyuk Ha, Jian-Ping Liu, Terje Alræk, Stephen Birch, Tae-Hun Kim, Yoon Jae Lee, Juan V.A. Franco, Jeremy Y. Ng, Holger Cramer
Perspectives on Integrative Medicine.2024; 3(3): 162. CrossRef - Bee Venom Acupuncture for Shoulder Pain: A Literature Review of Clinical Studies
Hyein Jeong, Soobin Jang, Jang-Kyung Park, Kyeong Han Kim, Jong Hyun Park, Gihyun Lee, Soo-Hyun Sung
Toxins.2024; 16(11): 501. CrossRef
- Current Status and Challenges of the Evidence for Cupping Therapy in Clinical Practice Guidelines in Korea
-
Seungwon Shin
-
Perspect Integr Med. 2024;3(2):74-85. Published online June 21, 2024
-
DOI: https://doi.org/10.56986/pim.2024.06.003
-
-
Graphical Abstract
 Abstract
PDF Supplementary Material
 - Clinical practice guidelines (CPGs) published in Korea were reviewed to evaluate up-to-date evidence and the recommendations for cupping therapy (CT) to inform clinicians and researchers for future studies. There were 14 CPGs (allergic rhinitis, ankle sprain, cervical pain, chronic low back pain, cold hands and feet, facial nerve palsy, Hwabyung, knee osteoarthritis, lumbar herniated intervertebral disk, migraine, osteoporosis, postoperative syndrome, shoulder pain, and traffic accident injury) with 29 recommendations for CT determined from “low” to “moderate” rated evidence. The levels of evidence were mostly downgraded due to the risk of bias and imprecision. The majority of recommendations for CT were graded as B or C. This comprehensive analysis underscores the imperative need for robust clinical research, including randomized controlled trials and observational studies using real-world data to enhance the quality of the evidence for CT. In addition, recommendations providing definite phases or scope of the target conditions/diseases and treatment regimens should be employed. This work lays a foundational step towards integrating CT into evidence-based clinical practice, emphasizing strategic directions for future research to bridge the gap between evidence and practice.
|
